203 related articles for article (PubMed ID: 15870932)
1. Multimodality therapy and significance of serum CYFRA21-1 for thymic carcinoma.
Suzuki M; Ando S; Iida T; Fujisawa T; Kimura H
Oncol Rep; 2005 Jun; 13(6):1127-31. PubMed ID: 15870932
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
[TBL] [Abstract][Full Text] [Related]
3. Thymic carcinoma: a report of 13 cases.
Lucchi M; Mussi A; Ambrogi M; Gunfiotti A; Fontanini G; Basolo F; Angeletti CA
Eur J Surg Oncol; 2001 Nov; 27(7):636-40. PubMed ID: 11669591
[TBL] [Abstract][Full Text] [Related]
4. Advanced stage thymomas and thymic carcinomas: results of multimodality treatments.
Lucchi M; Ambrogi MC; Duranti L; Basolo F; Fontanini G; Angeletti CA; Mussi A
Ann Thorac Surg; 2005 Jun; 79(6):1840-4. PubMed ID: 15919267
[TBL] [Abstract][Full Text] [Related]
5. [The diagnosis and treatment of the thymic carcinoma].
Moriyama H; Nishimura Y; Kuwabara K; Hishima T; Moriyama S
Gan To Kagaku Ryoho; 2003 May; 30(5):595-8. PubMed ID: 12795088
[TBL] [Abstract][Full Text] [Related]
6. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Uenishi T; Wakasa K; Suehiro S
Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728
[TBL] [Abstract][Full Text] [Related]
7. Multimodality therapy for patients with invasive thymoma disseminated into the pleural cavity: the potential role of extrapleural pneumonectomy.
Ishikawa Y; Matsuguma H; Nakahara R; Suzuki H; Ui A; Kondo T; Kamiyama Y; Igarashi S; Mori K; Kodama T; Yokoi K
Ann Thorac Surg; 2009 Sep; 88(3):952-7. PubMed ID: 19699926
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of multimodality therapy including extended resections in stage IVA thymoma.
Huang J; Rizk NP; Travis WD; Seshan VE; Bains MS; Dycoco J; Downey RJ; Flores RM; Park BJ; Rusch VW
J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1477-83; discussion 1483-4. PubMed ID: 18023668
[TBL] [Abstract][Full Text] [Related]
9. Persistent and aggressive treatment for thymic carcinoma. Results of a single-institute experience with 25 patients.
Maruyama R; Suemitsu R; Okamoto T; Kojo M; Aoki Y; Wataya H; Eguchi T; Nishiyama K; Seto T; Ichinose Y
Oncology; 2006; 70(5):325-9. PubMed ID: 17164588
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant radiotherapy for thymic epithelial tumor: treatment results and prognostic factors.
Kundel Y; Yellin A; Popovtzer A; Pfeffer R; Symon Z; Simansky DA; Oberman B; Sadezki S; Brenner B; Catane R; Levitt ML
Am J Clin Oncol; 2007 Aug; 30(4):389-94. PubMed ID: 17762439
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel and cisplatin with concurrent radiotherapy followed by surgery in locally advanced thymic carcinoma.
Fukuda M; Obase Y; Miyashita N; Kobashi Y; Mohri K; Ueno S; Hayama M; Shimizu K; Nishimura H; Nakata M; Oka M
Anticancer Res; 2007; 27(3B):1601-4. PubMed ID: 17595782
[TBL] [Abstract][Full Text] [Related]
12. Thymic carcinoma in children: a report from the Polish Pediatric Rare Tumors Study.
Stachowicz-Stencel T; Bien E; Balcerska A; Godzinski J; Synakiewicz A; Madziara W; Perek-Polnik M; Peregud-Pogorzelski J; Pietras W; Pobudejska A; Kurylak A; Mankowski P
Pediatr Blood Cancer; 2010 Jul; 54(7):916-20. PubMed ID: 20405512
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of serum cytokeratin 19 fragment and sialyl-Lewis x in non-small cell lung cancer.
Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Kameyama M; Suehiro S
Ann Thorac Surg; 2007 Jan; 83(1):216-21. PubMed ID: 17184666
[TBL] [Abstract][Full Text] [Related]
14. Topoisomerase 2alpha plays a pivotal role in the tumor biology of stage IV thymic neoplasia.
Liu JM; Wang LS; Huang MH; Hsu WH; Yen SH; Shiau CY; Li AF; Tiu CM; Tseng SW; Huang BS
Cancer; 2007 Feb; 109(3):502-9. PubMed ID: 17154178
[TBL] [Abstract][Full Text] [Related]
15. Treatment of pediatric malignant thymoma: long-term remission in a 14-year-old boy with EBV-associated thymic carcinoma by aggressive, combined modality treatment.
Niehues T; Harms D; Jürgens H; Göbel U
Med Pediatr Oncol; 1996 Jun; 26(6):419-24. PubMed ID: 8614381
[TBL] [Abstract][Full Text] [Related]
16. Thymoma and thymic carcinoma.
Venuta F; Anile M; Diso D; Vitolo D; Rendina EA; De Giacomo T; Francioni F; Coloni GF
Eur J Cardiothorac Surg; 2010 Jan; 37(1):13-25. PubMed ID: 19615917
[TBL] [Abstract][Full Text] [Related]
17. Serum CYFRA 21-1 in patients with invasive bladder cancer and its relevance as a tumor marker during chemotherapy.
Andreadis C; Touloupidis S; Galaktidou G; Kortsaris AH; Boutis A; Mouratidou D
J Urol; 2005 Nov; 174(5):1771-5; discussion 1775-6. PubMed ID: 16217281
[TBL] [Abstract][Full Text] [Related]
18. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.
Uenishi T; Yamazaki O; Tanaka H; Takemura S; Yamamoto T; Tanaka S; Nishiguchi S; Kubo S
Ann Surg Oncol; 2008 Feb; 15(2):583-9. PubMed ID: 17955299
[TBL] [Abstract][Full Text] [Related]
19. A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features.
Kim BK; Cho BC; Choi HJ; Sohn JH; Park MS; Chang J; Kim SK; Kim DJ; Chung KY; Lee CG; Kim JH; Yoo NC
Oncol Rep; 2008 Jun; 19(6):1525-31. PubMed ID: 18497960
[TBL] [Abstract][Full Text] [Related]
20. [Significance of CEA, SCC and Cyfra21-1 serum test in esophageal cancer].
Mao YS; Zhang DC; Zhao XH; Wang LJ; Qi J; Li XX
Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):457-60. PubMed ID: 14575569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
